Abstract
Evaluation of proliferative activity is a cornerstone in the classification of endocrine tumors; in pulmonary carcinoids, the mitotic count delineates typical carcinoid (TC) from atypical carcinoid (AC). Data on the reproducibility of manual mitotic counting and other methods of proliferation index evaluation in this tumor entity are sparse. Nine experienced pulmonary pathologists evaluated 20 carcinoid tumors for mitotic count (hematoxylin and eosin) and Ki-67 index. In addition, Ki-67 index was automatically evaluated with a software-based algorithm. Results were compared with respect to correlation coefficients (CC) and kappa values for clinically relevant grouping algorithms. Evaluation of mitotic activity resulted in a low interobserver agreement with a median CC of 0.196 and a median kappa of 0.213 for the delineation of TC from AC. The median CC for hotspot (0.658) and overall (0.746) Ki-67 evaluation was considerably higher. However, kappa values for grouped comparisons of overall Ki-67 were only fair (median 0.323). The agreement of manual and automated Ki-67 evaluation was good (median CC 0.851, median kappa 0.805) and was further increased when more than one participant evaluated a given case. Ki-67 staining clearly outperforms mitotic count with respect to interobserver agreement in pulmonary carcinoids, with the latter having an unacceptable low performance status. Manual evaluation of Ki-67 is reliable, and consistency further increases with more than one evaluator per case. Although the prognostic value needs further validation, Ki-67 might perspectively be considered a helpful diagnostic parameter to optimize the separation of TC from AC.
Similar content being viewed by others
References
Zahel T, Krysa S, Herpel E et al (2012) Phenotyping of pulmonary carcinoids and a Ki-67-based grading approach. Virchows Arch 460:299–308
Warth A, Krysa S, Zahel T et al (2010) S100 protein positive sustentacular cells in pulmonary carcinoids and thoracic paragangliomas: differential diagnostic and prognostic evaluation. Pathologe 31:379–384
Warth A, Herpel E, Krysa S et al (2009) Chromosomal instability is more frequent in metastasized than in non-metastasized pulmonary carcinoids but is not a reliable predictor of metastatic potential. Exp Mol Med 41:349–353
Rekhtman N (2010) Neuroendocrine tumors of the lung: an update. Arch Pathol Lab Med 134:1628–1638
Warren WH, Gould VE, Faber LP et al (1985) Neuroendocrine neoplasms of the bronchopulmonary tract. A classification of the spectrum of carcinoid to small cell carcinoma and intervening variants. J Thorac Cardiovasc Surg 89:819–825
Ducrocq X, Thomas P, Massard G et al (1998) Operative risk and prognostic factors of typical bronchial carcinoid tumors. Ann Thorac Surg 65:1410–1414
Fink G, Krelbaum T, Yellin A et al (2001) Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature. Chest 119:1647–1651
Travis WD (2010) Advances in neuroendocrine lung tumors. Ann Oncol 21(Suppl 7):vii65–vii71
Hage R, de la Riviere AB, Seldenrijk CA et al (2003) Update in pulmonary carcinoid tumors: a review article. Ann Surg Oncol 10:697–704
Skov BG, Holm B, Erreboe A et al (2010) ERCC1 and Ki67 in small cell lung carcinoma and other neuroendocrine tumors of the lung: distribution and impact on survival. J Thorac Oncol 5:453–459
Rindi G, Falconi M, Klersy C et al (2012) TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. J Natl Cancer Inst 104:764–777
Rindi G, Kloppel G, Alhman H et al (2006) TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 449:395–401
Santinelli A, Ranaldi R, Baccarini M et al (1999) Ploidy, proliferative activity, p53 and bcl-2 expression in bronchopulmonary carcinoids: relationship with prognosis. Pathol Res Pract 195:467–474
Bohm J, Koch S, Gais P et al (1996) Prognostic value of MIB-1 in neuroendocrine tumours of the lung. J Pathol 178:402–409
Granberg D, Wilander E, Oberg K et al (2000) Prognostic markers in patients with typical bronchial carcinoid tumors. J Clin Endocrinol Metab 85:3425–3430
Das-Neves-Pereira JC, Bagan P, Milanez-de-Campos JR, et al. (2008) Individual risk prediction of nodal and distant metastasis for patients with typical bronchial carcinoid tumors. Eur J Cardiothorac Surg 34:473–7; discussion 477–8
Grimaldi F, Muser D, Beltrami CA, et al. (2011) Partitioning of bronchopulmonary carcinoids in two different prognostic categories by ki-67 score. Front Endocrinol (Lausanne) 2:20
Walts AE, Ines D, Marchevsky AM (2012) Limited role of Ki-67 proliferative index in predicting overall short-term survival in patients with typical and atypical pulmonary carcinoid tumors. Mod Pathol 25:1258–1264
Hasegawa T, Yamamoto S, Nojima T et al (2002) Validity and reproducibility of histologic diagnosis and grading for adult soft-tissue sarcomas. Hum Pathol 33:111–115
Gunia S, Kakies C, Erbersdobler A et al (2012) Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa. J Clin Pathol 65:715–720
Ladekarl M (1998) Objective malignancy grading: a review emphasizing unbiased stereology applied to breast tumors. APMIS Suppl 79:1–34
Barry M, Sinha SK, Leader MB et al (2001) Poor agreement in recognition of abnormal mitoses: requirement for standardized and robust definitions. Histopathology 38:68–72
Coindre JM, Trojani M, Contesso G et al (1986) Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer 58:306–309
Silverberg SG (1976) Reproducibility of the mitosis count in the histologic diagnosis of smooth muscle tumors of the uterus. Hum Pathol 7:451–454
Montironi R, Collan Y, Scarpelli M et al (1988) Reproducibility of mitotic counts and identification of mitotic figures in malignant glial tumors. Appl Pathol 6:258–265
Gilles FH, Tavare CJ, Becker LE et al (2008) Pathologist interobserver variability of histologic features in childhood brain tumors: results from the CCG-945 study. Pediatr Dev Pathol 11:108–117
Svanholm H, Starklint H, Barlebo H et al (1990) Histological evaluation of prostatic cancer. (II): reproducibility of a histological grading system. APMIS 98:229–236
Tsuda H, Akiyama F, Kurosumi M et al (2000) Evaluation of the interobserver agreement in the number of mitotic figures of breast carcinoma as simulation of quality monitoring in the Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) protocol. Jpn J Cancer Res 91:451–457
van Diest PJ, Baak JP, Matze-Cok P et al (1992) Reproducibility of mitosis counting in 2,469 breast cancer specimens: results from the Multicenter Morphometric Mammary Carcinoma Project. Hum Pathol 23:603–607
Biesterfeld S (1997) Methodologic aspects of a standardized evaluation of mitotic activity in tumor tissues. Pathologe 18:439–444
Yadav KS, Gonuguntla S, Ealla KK et al (2012) Assessment of interobserver variability in mitotic figure counting in different histological grades of oral squamous cell carcinoma. J Contemp Dent Pract 13:339–344
Tapia C, Kutzner H, Mentzel T et al (2006) Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 30:83–89
Schimming TT, Grabellus F, Roner M et al (2012) pHH3 immunostaining improves interobserver agreement of mitotic index in thin melanomas. Am J Dermatopathol 34:266–269
Yamaguchi U, Hasegawa T, Sakurai S et al (2006) Interobserver variability in histologic recognition, interpretation of KIT immunostaining, and determining MIB-1 labeling indices in gastrointestinal stromal tumors and other spindle cell tumors of the gastrointestinal tract. Appl Immunohistochem Mol Morphol 14:46–51
Mengel M, von Wasielewski R, Wiese B et al (2002) Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 198:292–299
Hsu CY, Ho DM, Yang CF et al (2003) Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods. Mod Pathol 16:951–957
Acknowledgments
Iver Petersen, Philipp A. Schnabel, Klaus Junker, Alicia Morresi-Hauf, and Florian Länger are acknowledged for their valuable discussions.
Conflict of interest
None.
Author information
Authors and Affiliations
Consortia
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Supplementary Figure 1
Distribution of mitotic counts for all observers and all evaluated cases. (PPT 114 kb)
Supplementary Figure 2
Distribution of overall Ki-67 count for all observers and all evaluated cases. Automated evaluation is given as a reference on the right hand side of each case (red bar). (PPT 115 kb)
Rights and permissions
About this article
Cite this article
Warth, A., Fink, L., Fisseler-Eckhoff, A. et al. Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids. Virchows Arch 462, 507–513 (2013). https://doi.org/10.1007/s00428-013-1408-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00428-013-1408-2